Among which, mutationally activated BRAF has been identified in a variety of cancers recently [32] and it occurs in a non-overlapping occurrence in many cancers such as melanomas, colorectal carcinomas, papillary thyroid carcinomas, serous ovarian carcinomas and lung cancers [21], [33]. This evidence concerns the gene BRAF and colorectal carcinoma.